Detalhe da pesquisa
1.
Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL.
Circulation
; 144(22): 1750-1759, 2021 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34706555
2.
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
Circulation
; 144(23): 1845-1855, 2021 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34710343
3.
Reduction in Revascularization With Icosapent Ethyl: Insights From REDUCE-IT Revascularization Analyses.
Circulation
; 143(1): 33-44, 2021 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33148016
4.
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
N Engl J Med
; 380(1): 11-22, 2019 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30415628
5.
EPA and DHA containing phospholipids have contrasting effects on membrane structure.
J Lipid Res
; 62: 100106, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34400132
6.
REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States.
Circulation
; 141(5): 367-375, 2020 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31707829
7.
Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies.
Eur Heart J Suppl
; 22(Suppl J): J34-J48, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33061866
8.
Response by Bhatt et al to Letter Regarding Article, "REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States".
Circulation
; 141(21): e834-e835, 2020 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32453660
9.
Icosapent ethyl: Eicosapentaenoic acid concentration and triglyceride-lowering effects across clinical studies.
Prostaglandins Other Lipid Mediat
; 125: 57-64, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27418543
10.
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT.
J Am Heart Assoc
; 12(5): e026756, 2023 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36802845
11.
Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE-IT.
J Am Heart Assoc
; 11(7): e024999, 2022 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35377160
12.
Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction.
J Am Coll Cardiol
; 79(17): 1660-1671, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35483753
13.
Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI.
J Am Heart Assoc
; 11(6): e022937, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35261279
14.
Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT.
J Am Coll Cardiol
; 78(15): 1525-1537, 2021 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34620410
15.
A randomized trial of icosapent ethyl in ambulatory patients with COVID-19.
iScience
; 24(9): 103040, 2021 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462732
16.
Eicosapentaenoic acid (EPA) has optimal chain length and degree of unsaturation to inhibit oxidation of small dense LDL and membrane cholesterol domains as compared to related fatty acids in vitro.
Biochim Biophys Acta Biomembr
; 1862(7): 183254, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32135144
17.
Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study.
Cardiol Ther
; 8(1): 79-90, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30788718
18.
Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Atherogenic Lipid/Lipoprotein, Apolipoprotein, and Inflammatory Parameters in Patients With Elevated High-Sensitivity C-Reactive Protein (from the ANCHOR Study).
Am J Cardiol
; 124(5): 696-701, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31277790
19.
Icosapent ethyl reduces atherogenic markers in high-risk statin-treated patients with stage 3 chronic kidney disease and high triglycerides.
Postgrad Med
; 131(6): 390-396, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31306043
20.
Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT.
J Am Coll Cardiol
; 73(22): 2791-2802, 2019 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30898607